|
Please
download and print the PDF file below:
|
|
|
|
Troy A. Russell, MSN, RN, APRN, BC, CNN
|
Troy A. Russell, MSN, RN, APRN, BC, CNN,
is a Nephrology Nurse Practitioner, The VA Medical
Center, Nashville, TN. He is Chairperson,
Certification Committee, and Chairperson, CNN
Test Committee, for the Nephrology Nursing
Certification Commission (NNCC). He is a member
of the Music City Chapter of ANNA.
|
Proteinuria has been recognized in association with diabetes mellitus as early as the 18th century.
This form of renal disease is known as diabetic nephropathy. It is now clear that diabetic
nephropathy is the principal cause of end stage renal disease (ESRD) in the western
world. According to reports by the United States Renal Data System (USRDS), in the past
two decades there has been a continual increase in the incidence of ESRD among patients
with diabetes. Many patients have diabetes that progresses to diabetic nephropathy, which is
often not discovered until overt nephropathy is present. Many of the complications of diabetes
could be minimized if patients received a comprehensive health maintenance program that
includes vigorous cardiac risk reduction; routine eye examinations; routine foot examinations;
screening and treatment for microalbuminuria; optimal hypertension management;
and improved glycemic control. Hence, the key is not only prudent screening of these patients,
but referral as well. Using a case study approach, this article illustrates the care of patients
with diabetic nephropathy in type 1 diabetes mellitus.
|
|
CE
RELATED INFORMATION |
|
This
offering for 2.5 contact
hours is being provided by
the
American
Nephrology Nurses Association
(ANNA), which
is accredited as a provider
and approver of continuing
education in nursing by
the American Nurses
Credentialing Center-Commission
on Accreditation (ANCCCOA).
This educational activity
is approved by most states
and specialty organizations
that recognize the ANCC-COA
accreditation process. ANNA
is an approved provider of
continuing education in nursing
by the California Board of
Registered Nursing, BRN Provider
No. 00910; and the Kansas
State Board of Nursing, Provider
No. LT0148-0738. This offering
is accepted for RN and LPN
relicensure in Kansas
|
|
Goal:
Examine the care of patients with diabetic nephropathy in type 1 diabetes mellitus.
Objectives:
1. Describe the pathophysiology of diabetic nephropathy.
2. List components of a comprehensive health maintenance
program for patients with diabetes mellitus.
3. Discuss areas of patient teaching critical to achieving
desired goals of therapy effectiveness.
|
AUTHOR DISCLOSURE
STATEMENT |
Troy A. Russell, has
no conflicts of interest to disclose.
|
ANNA and HDCN CE POLICY STATEMENTS |
The CE policy and disclosure statements of the American Nephrology
Nurses' Association are given in detail on the Symposium
Home Page. The CE policy statements of HDCN are listed on
this page. |